Orion Biotechnology Canada Acquires K2Biomedical

OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical research company based in Cracow, Poland.  The acquisition will add drug development capabilities to Orion Biotechnology in Europe. Founded in 2015, K2Biomedical was initially focused on the prevention of Sexually … Read moreOrion Biotechnology Canada Acquires K2Biomedical

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com